These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1136209)

  • 21. [Blood as a medium for incubating isolated organs: pharmacokinetic studies with 3H-labelled cardiac glycosides].
    Peters T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):242-3. PubMed ID: 5804266
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolism and intestinal absorption of cardiac glycosides].
    Lauterbach F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative studies on the uptake of cardiac glycosides by the cell].
    Hüsten J; Ruiz-Torres A
    Verh Dtsch Ges Inn Med; 1969; 75():396-9. PubMed ID: 5400163
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principles and directives for practical treatment with cardiac glycosides].
    Dörffel EF
    Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic use of digitalis and substances with analogous action. Lecture IV].
    Messini M
    Clin Ter; 1971 Feb; 56(4):307-40. PubMed ID: 5581067
    [No Abstract]   [Full Text] [Related]  

  • 27. [Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides].
    Kukes VG; Volkov RIu
    Kardiologiia; 1977 Sep; 17(9):135-42. PubMed ID: 144820
    [No Abstract]   [Full Text] [Related]  

  • 28. [Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication)].
    Jordan D; Junge N; Schröder K; Schulz K; Spangenberg K; Wüstenberg PW
    Z Arztl Fortbild (Jena); 1975 Oct; 69(19):1017-21. PubMed ID: 1210392
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cumulative effect of cardiac glycosides. (Review)].
    Angarskaia MA; Liubartseva LA; Sokolova VE
    Farmakol Toksikol; 1969; 32(6):745-6. PubMed ID: 4909670
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metabolic degradation of 3H-labelled cardiac glycosides by the isolated perfused guinea pig liver].
    Kolenda KD; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):374-5. PubMed ID: 4253809
    [No Abstract]   [Full Text] [Related]  

  • 31. Disease-related alterations in cardiac glycoside disposition.
    Ochs HR; Greenblatt DJ; Bodem G; Dengler HJ
    Clin Pharmacokinet; 1982; 7(5):434-51. PubMed ID: 6754209
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the active or passive enteral resorption of cardiac glycosides].
    Mentz P; Witzleben H; Förster W
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):126-40. PubMed ID: 4674599
    [No Abstract]   [Full Text] [Related]  

  • 33. Biliary excretion of cardiac glycosides.
    Russell JQ; Klaassen CD
    J Pharmacol Exp Ther; 1973 Sep; 186(3):455-62. PubMed ID: 4728329
    [No Abstract]   [Full Text] [Related]  

  • 34. A simple approach to follow the metabolic degradation of cardiac glycosides in vivo.
    Glover A; Kokenge F; Lüllmann H; Peters T; Seiler KU; van Zweiten PA
    Klin Wochenschr; 1971 Oct; 49(19):1062-5. PubMed ID: 5115325
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasmatic levels and urinary elimination of K-strophanthoside after intravenous administration in normal humans].
    Marzo A; Ghirardi P; Riva D; Zaini G; Matteoli E; Marchetti G
    Boll Soc Ital Biol Sper; 1973 Jul; 49(11):633-6. PubMed ID: 4790664
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of administration of activated charcoal and fibre on absorption, excretion and steady state blood levels of digoxin and digitoxin. Evidence for intestinal secretion of the glycosides.
    Reissell P; Manninen V
    Acta Med Scand Suppl; 1982; 668():88-90. PubMed ID: 6963097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Direct determination of intestinal absorption of tritium-labelled cardiac glycosides by measurement of portal and arterial concentrations and volume of portal vein flow in guinea pigs].
    Haass A; Peters T
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):343. PubMed ID: 4253785
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study on the membrane permeability of cardiac using drugs (g-Strophantin, Digoxin and Oxyfedrin) micro-autoradiography in guinea pig heart].
    Löhr E; Makoski HB; Göbbeler T; Strötges MW
    Arzneimittelforschung; 1971 Jul; 21(7):921-7. PubMed ID: 5109500
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biochemical aspects of the therapeutic use of cardiac glycosides].
    Savitskiĭ NN
    Ter Arkh; 1972 Jan; 44(1):5-11. PubMed ID: 5017540
    [No Abstract]   [Full Text] [Related]  

  • 40. The binding of 3H-peruvoside by guinea pig isolated atria.
    Kuschinsky K; Lüllmann H; van Zwieten PA
    Arzneimittelforschung; 1968 Dec; 18(12):1602-5. PubMed ID: 5756260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.